Compound Detail
CHEMBL1597349
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL1597349 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | NCPFBIXFCFNTIV-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
1
Known Names
Molecular Properties
373.4
MW (Da)
2.56
ALogP
7
HBA
1
HBD
69.6
PSA (Ų)
0.86
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 4.36
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 4.36 | 4.36 | 44000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 44000.0 | nM | 4.36 | Inhibition of human His-tagged Frataxin/GST-tagged mono ubiquitin interaction ex... | 23506486 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 23506486 | 10.1021/jm3017199 | Unchecked | 2 |
Data from ChEMBL 36 via Core Engine